Shuyi Si

Statistics

Publications

Citations

4.2K

H-Index

Active since

2004

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

University of Rochester

Florida State University

Ningxia Medical University

Shuyi Si is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in pharmacology, life sciences, and drug discovery.

ORCID

Publications per year

2004–2024

Publications

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Weijia Kong, Jing Wei, Parveen Abidi et al. · Nature Medicine · 2004 · 1.4K citations

Pharmacy, Pharmacology, Pharmacotherapy +4

Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression

Weijia Kong, Hao Zhang, Danqing Song et al. · Metabolism · 2008 · 265 citations

Medicine, Endocrinology, Pharmacology +14

Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism

Yan Wang, Jia‐Wen Shou, Xiaoyang Li et al. · Metabolism · 2017 · 201 citations

Life Sciences, Microbiology, Nutritional Sciences +16

MicroRNAs 185, 96, and 223 Repress Selective High-Density Lipoprotein Cholesterol Uptake through Posttranscriptional Inhibition

Li Wang, Xiaojian Jia, Yu Du et al. · Molecular and Cellular Biology · 2013 · 155 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

The novel coronary artery disease risk gene <i>JCAD/KIAA1462</i> promotes endothelial dysfunction and atherosclerosis

Suowen Xu, Yanni Xu, Peng Liu et al. · European Heart Journal · 2019 · 114 citations · Full text

Medicine, Genetics, Molecular Genetics +17

1–5 of 66